#apotex Tech News.
2 stories in the last 7 days
The latest apotex news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks apotex across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Apotex Health Corp. and backers raised C$1.3 billion ($932 million) in a Toronto IPO priced at C$24 per share, the high end of the range. The generic drug maker sold 35.4 million shares, and selling holders divested about 18.8 million shares. It is Canada's largest IPO since 2021.
Apotex Health Corp. expects its Toronto IPO to price at C$24, the top of the C$20 to C$24 range, according to people familiar with the matter. The offering, which includes a treasury component and existing shareholder sales, is expected to raise C$1.3 billion. That would be Canada's largest IPO since 2021.
Summaries by ByteBrief